Innovating Works

NOVARTIS FARMACEUTICA

Activa
HBPTC: Hydrogen Bonding Phase Transfer Catalysis NOVARTIS FARMACEUTICA participó en un H2020: ERC-2018-ADG The objective of the research described in this proposal is to develop a new mode of activation for catalysis leading to more sustainable ca...
2019-04-23 - 2024-12-31 | Financiado
IM2PACT: Investigating Mechanisms and Models Predictive of Accessibility of Therapeutics IM2PACT Into The B... NOVARTIS FARMACEUTICA participó en un H2020: H2020-JTI-IMI2-2017-12-two-stage The overall aim is to further the understanding of the BBB in health and disease states towards the development of innovative brain delivery...
2018-12-14 - 2024-12-31 | Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.